Sovantinib impurity as well as preparation method and application thereof

The invention belongs to the field of pharmacy, and provides sovantinib impurity as shown in a formula (I) and a formula (II) as well as a preparation method and an application thereof..

Medienart:

Patent

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Europäisches Patentamt - (2022) vom: 25. Feb. Zur Gesamtaufnahme - year:2022

Sprache:

Englisch

Beteiligte Personen:

LIU BO [VerfasserIn]
LI WENJI [VerfasserIn]
TAN YUNBING [VerfasserIn]
CHEN ZHIGANG [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

615
A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d)
A61P: Specific therapeutic activity of chemical compounds or medicinal preparations
C07D: Heterocyclic compounds (macromolecular compounds c08)
Che
G01N: Investigating or analysing materials by determining their chemical or physical properties (measuring or testing processes other than immunoassay, involving enzymes or microorganisms c12m, c12q)
Tec

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2022-02-25, Last update posted on www.tib.eu: 2022-09-10, Last updated: 2023-02-09

Patentnummer:

CN114085214

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA013525379